CMV Disease in Stem Cell Transplantation: Prevention and Drug Resistance

VOORHEES, N.J., Aug. 14 Cytomegalovirus (CMV) is asignificant cause of morbidity and mortality in recipients of hematopoieticstem cell transplantation. The clinical manifestations of CMV disease areserious and range from gastrointestinal disease to life-threatening pneumonia,myelosuppression, retinitis, and encephalitis.

In order to prevent CMV infection and reduce CMV drug resistance, it isvital that healthcare professionals involved in the treatment of hematopoieticstem cell transplant recipients understand current strategies for managementof CMV, including prophylaxis and treatment. To address the need for educationon CMV management, Robert Michael Educational Institute LLC (RMEI) andPostgraduate Institute for Medicine (PIM) have jointly sponsored a freecontinuing education monograph for physicians and clinical pharmacists.

Faculty authors for this activity include infectious disease expertsMichael J. Boeckh, MD, from the Fred Hutchinson Cancer Research Center and theUniversity of Washington School of Medicine in Seattle, Washington and SunwenChou, MD, from the Oregon Health & Science University in Portland, Oregon.

Healthcare professionals can download a copy of this self-study activityby visiting: http://www.RMEI.com/BMTmono.

This continuing education activity is jointly sponsored by RMEI andPostgraduate Institute for Medicine and is supported by an educational grantfrom ViroPharma, Incorporated.

"Robert Michael Educational Institute LLC recognizes that continuingmedical education plays a crucial role in the provision of quality health careand is dedicated to offering professionals meaningful opportunities forlifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a full-service medical education company dedicated to providingcomprehensive medical education to healthcare providers. RMEI works closelywith medical experts to design activities that improve diagnosis andtreatment. These activities include national and international symposia,teleconferences, live meetings, enduring print materials, and interactiveInternet programs.

For additional educational offerings, please visit http://www.RMEI.com.

SOURCE Robert Michael Educational Institute LLC

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...